Yuan, Ge-Heng <br/><br/>
Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study.  [electronic resource] 

 -  Chinese medical journal  Aug 2012 
 - 2677-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2542-5641 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Diabetes Mellitus, Type 2--blood<br/>Exenatide<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--adverse effects<br/>Insulin Resistance<br/>Male<br/>Metformin--adverse effects<br/>Middle Aged<br/>Nausea--chemically induced<br/>Obesity--blood<br/>Peptides--adverse effects<br/>Venoms--adverse effects<br/>Weight Loss--drug effects